GILDGilead Sciences, Inc. Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Drug Manufacturers - General

Current Price: $139.71 (+0.00% today)

Market Cap: $173.44B

P/E (TTM): 20.40

Forward P/E (FY1): 16.10

EPS Growth: 11.4%

Analyst Upside: 14.8%

Relative Strength (RS%): 1

-11.2% from 52-week high

Back to Scanner

GILD

NASDAQRS 1Score 30

Gilead Sciences, Inc.

HealthcareDrug Manufacturers - General$173.44B1 setup passing
$139.71
0.0% ($0.00)
-11.2% from 52W High
P/E (TTM)
20.40
Fwd P/E
16.10
PEG
0.57
Analyst Upside
+14.8%
EPS Growth
11.4%
Gross Margin
80.8%
ROE
41.0%
D/E
1.09
Div Yield
2.3%
Avg Volume
4.9M

Price Chart

Key Levels

SMA 200
$124.09
SMA 50
$144.33
Price
$139.71
52W High
$157.33
Target
$160.35

Setup Radar

1/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst